Study Design Herb name Quality Rx N Cx N Outcome measuresa Side effects Results Maurer et al. [14 ] Randomized, double-blind, placebo-controlled, parallel G. biloba (EGb761) 80 mg tid for 3 months3 10 10 SKT No adverse events
Placebo (SKT) (
) Schneider et al. [15 ] Randomized, double-blind, placebo-controlled, parallel, multi-center G. biloba (EGb761) 120 mg or 240 mg per day for 26 weeks4 169 (120 mg) 170 (240 mg) 174 ADAS-cog, ADCS-CGIC Related serious adverse events (1% in 120 mg Gp and 2% in 240 mg Gp)
PlaceboMazza et al. [16 ] Randomized, double-blind, placebo-controlled, parallel G. biloba (EGb761) 160 mg per day for 24 weeks5 25 25b , 26c SKT MMSE CGI No adverse events (1)
Donepezil(2)
Placebo (SKT, CGI) (
)(3)
Placebo (MMSE) Xu et al. [17 ] Randomized, double-blind, placebo-controlled, parallel, multi-center Huperzine A 0.2 mg b.i.d. for 8 weeks 3 50 53 Wechsler, Hasegawa, MMSE No severe side effects
Placebo (
)Zhang et al. [18 ] Randomized, double-blind, placebo-controlled, parallel, multi-center Huperzine A 0.4 mg per day for 12 weeks 4 100 102 ADAS MMSE Ankle edema, insomnia (3%)
Placebo (
)Heo et al. [19 ] Randomized, non-blinding, controlled, parallel Ginseng 4.5 g or 9.0 g per day for 12 weeks 1 15 (9 g)15 (4.5 g), 31 ADAS, MMSE, CDR Nausea, fever (13%) (1) Rx (9 g)
Cx (ADAS-cog, CDR) (
)(2)
(MMSE)